Literature DB >> 15772181

Guidelines and risk factor management.

P Primatesta.   

Abstract

Efforts to reduce the death rate from cardiovascular disease in the UK are beginning to make a difference.

Entities:  

Mesh：

Year:  2005        PMID： 15772181      PMCID： PMC1768810          DOI： 10.1136/hrt.2004.048058

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  10 in total

1.  Improved hypertension management and control: results from the health survey for England 1998.

Authors:  P Primatesta; M Brookes; N R Poulter
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Coronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and women.

Authors:  J R Emberson; P H Whincup; D A Lawlor; D Montaner; S Ebrahim
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

3.  Improving secondary prevention in coronary bypass patients: closing the audit loop.

Authors:  T N Martin; R J Irving; M Sutherland; K Sutherland; P Bloomfield
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

4.  Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.

Authors: 
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

5.  The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.

Authors:  D J Toobert; S E Hampson; R E Glasgow
Journal:  Diabetes Care       Date:  2000-07       Impact factor: 19.112

6.  Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

Authors:  B Williams; N R Poulter; M J Brown; M Davis; G T McInnes; J F Potter; P S Sever; S McG Thom
Journal:  J Hum Hypertens       Date:  2004-03       Impact factor: 3.012

7.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Authors:  Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood
Journal:  Eur Heart J       Date:  2003-09       Impact factor: 29.983

8.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

Authors:  Rory Collins; Jane Armitage; Sarah Parish; Peter Sleigh; Richard Peto
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245
  10 in total
  1 in total

1.  Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndrome: final data of the nationwide cross-sectional 'CardioRisk' project.

Authors:  Ashraf Reda; Ahmed Bendary; Atef Elbahry; Elsayed Farag; Tamer Mostafa; Hazem Khamis; Moheb Wadie; Mohamed Bendary; Bassant Abdoul Azeem; Rehab Salah
Journal:  J Public Health Afr       Date:  2021-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.